Holen Sie sich die Stockscreener-App
6.27
3.39%
-0.22
Handel nachbörslich:
6.25
-0.02
-0.32%
Schlusskurs vom Vortag:
$6.49
Offen:
$6.42
24-Stunden-Volumen:
13,471
Relative Volume:
0.43
Marktkapitalisierung:
$54.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.47%
1M Leistung:
-14.29%
6M Leistung:
+20.58%
1J Leistung:
-1.42%
1-Tages-Spanne:
$5.97
$6.42
1-Wochen-Bereich:
$5.97
$6.85
52-Wochen-Spanne:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Firmenname
Neuehealth Inc
Sektor
Branche
Telefon
612-238-1321
Adresse
9250 NW 36TH STREET, DORAL
Vergleichen Sie NEUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.27 | 54.07M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
525.05 | 480.27B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
428.89 | 97.10B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
322.40 | 87.41B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
63.66 | 80.26B | 372.81B | 4.61B | 6.33B | 3.66 |
|
CNC
Centene Corp
|
61.93 | 30.72B | 163.07B | 3.31B | -490.00M | 6.24 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Eingeleitet | Goldman | Buy |
| 2021-07-19 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Neuehealth Inc Aktie (NEUE) Neueste Nachrichten
NeueHealth StockIs the Proposed Acquisition of NeueHealth By An Affiliate of Its Controlling Shareholder Fair to NEUE Shareholders?Kehoe Law Firm, P.C. Investigating - ACCESS Newswire
NeueHealth, Inc. (NYSE:NEUE) Q4 2024 Earnings Call Transcript - MSN
Virtu Financial LLC Takes Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc. Earnings Call Highlights Growth and Acquisition - TipRanks
NeueHealth Inc. (NEUE) reports earnings - Quartz
NeueHealth: Q4 Earnings Snapshot - Midland Daily News
NeueHealth Inc (NEUE) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeueHealth Inc. Reports Strong 2024 Financial Performance - TipRanks
NeueHealth Inc reports results for the quarter ended December 31Earnings Summary - TradingView
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - Nasdaq
NEUEHEALTH Earnings Results: $NEUE Reports Quarterly Earnings - Nasdaq
NeueHealth Reports Fourth Quarter and Full Year 2024 Results - TradingView
NeueHealth Crushes Growth Targets: Consumer Base Surges 48% as 2024 Hits All-Time Highs - Stock Titan
NeueHealth reaches modified repayment agreement with CMS By Investing.com - Investing.com Australia
NeueHealth reaches modified repayment agreement with CMS - Investing.com India
NeueHealth IncOn March 13, Insurance Units Modify Repayment Agreements With CMSSEC Filing - Marketscreener.com
NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February - Defense World
NeueHealth Executives Sell Shares Worth Over $411K - TradingView
neuehealth EVP Tomas Orozco sells $13,235 in stock By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan sells $117,004 in stock By Investing.com - Investing.com Australia
Neuehealth’s chief accounting officer sells $5,523 in stock transactions By Investing.com - Investing.com South Africa
NeueHealth CFO Jay Matushak sells $16,892 in common stock - Investing.com India
Neuehealth’s chief accounting officer sells $5,523 in stock transactions - Investing.com India
neuehealth EVP Tomas Orozco sells $13,235 in stock - Investing.com India
neuehealth gc Craig Jeffery Michael sells $7,940 in stock - Investing.com
neuehealth gc Craig Jeffery Michael sells $7,940 in stock By Investing.com - Investing.com UK
NeueHealth CEO George Mikan sells $117,004 in stock - Investing.com
NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday - Defense World
NeueHealth CEO George Mikan III sells $203,009 in stock By Investing.com - Investing.com Australia
NeueHealth CEO George Mikan III sells $203,009 in stock - Investing.com India
NeueHealth EVP Tomas Orozco sells $4,599 in stock By Investing.com - Investing.com South Africa
NeueHealth GC Craig Michael sells $8,929 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock - Investing.com India
NeueHealth GC Craig Michael sells $8,929 in stock - Investing.com India
Neuehealth CFO Matushak sells $14,672 in stock By Investing.com - Investing.com South Africa
NeueHealth chief accounting officer sells $5,756 in stock By Investing.com - Investing.com South Africa
NeueHealth Executives Sell Shares - TradingView
Neuehealth CFO Matushak sells $14,672 in stock - Investing.com
NeueHealth (NEUE) Projected to Post Earnings on Wednesday - Defense World
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025 - The Bakersfield Californian
When Will NeueHealth Reveal Its Q4 Performance? Key Date for Investors - StockTitan
Finanzdaten der Neuehealth Inc-Aktie (NEUE)
Es liegen keine Finanzdaten für Neuehealth Inc (NEUE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuehealth Inc-Aktie (NEUE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Scherman Jeffrey J | Chief Accounting Officer |
Mar 14 '25 |
Sale |
6.13 |
353 |
2,164 |
12,234 |
| Craig Jeffery Michael | GC & Corporate Secretary |
Mar 13 '25 |
Sale |
6.74 |
2,595 |
17,490 |
21,003 |
| Craig Jeffery Michael | GC & Corporate Secretary |
Mar 14 '25 |
Sale |
6.13 |
899 |
5,511 |
20,104 |
| Orozco Tomas | EVP, Consumer Care |
Mar 13 '25 |
Sale |
6.74 |
3,540 |
23,860 |
30,551 |
| Orozco Tomas | EVP, Consumer Care |
Mar 14 '25 |
Sale |
6.13 |
1,226 |
7,515 |
29,325 |
| Matushak Jay | Chief Financial Officer |
Mar 13 '25 |
Sale |
6.74 |
4,448 |
29,980 |
41,592 |
| Matushak Jay | Chief Financial Officer |
Mar 14 '25 |
Sale |
6.13 |
1,542 |
9,452 |
40,050 |
| Mikan George Lawrence III | CEO & President |
Mar 13 '25 |
Sale |
6.74 |
35,896 |
241,939 |
261,894 |
| Mikan George Lawrence III | CEO & President |
Mar 14 '25 |
Sale |
6.13 |
12,440 |
76,257 |
249,454 |
| Scherman Jeffrey J | Chief Accounting Officer |
Mar 11 '25 |
Sale |
6.85 |
427 |
2,925 |
8,482 |
2.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):